Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
D000477:Alkylating Agents / Q000627:therapeutic use; D000585:Aminacrine / Q000627:therapeutic use; D000609:Aminoacridines / Q000627:therapeutic use*; D000677:Amsacrine; D000818:Animals; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002460:Cell Line; D004351:Drug Resistance; D007941:Leukemia P388 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D009279:Naphthacenes / Q000627:therapeutic use; D009368:Neoplasm Transplantation
D000477:Alkylating Agents; D000609:Aminoacridines; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009279:Naphthacenes; D000677:Amsacrine; D000585:Aminacrine